LUP Statistics
Record
- Title
- RISK FOR LOW VISUAL ACUITY AFTER 1 AND 2 YEARS OF TREATMENT WITH RANIBIZUMAB OR BEVACIZUMAB FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- Type
- Journal Article
- Publ. year
- 2017
- Author/s
- Westborg, Inger; Albrecht, Susanne; Rosso, Aldana
- Department/s
- Radiology Diagnostics, Malmö
- In LUP since
- 2017-02-14
Downloads
Total | This Year | This Month |
365 | 15 | 0 |
United States of America | 237 (65%) |
Germany | 31 (9%) |
Sweden | 18 (5%) |
China | 15 (4%) |
United Kingdom of Great Britain and Northern Ireland | 14 (4%) |
France | 7 (2%) |
Australia | 6 (2%) |
Canada | 5 (1%) |
Netherlands (Kingdom of the) | 5 (1%) |
Portugal | 3 (1%) |
Italy | 3 (1%) |
Denmark | 3 (1%) |
Finland | 2 (1%) |
Brazil | 2 (1%) |
Egypt | 2 (1%) |
Unknown | 1 (0%) |
Estonia | 1 (0%) |
Philippines | 1 (0%) |
Taiwan (China) | 1 (0%) |
Mexico | 1 (0%) |
Ireland | 1 (0%) |
Poland | 1 (0%) |
Spain | 1 (0%) |
India | 1 (0%) |
Romania | 1 (0%) |